Internal Medicine, Pulmonary Disease · Yardley, PA
NPI
1306892401
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1000 Floral Vale Blvd, Suite 125
Yardley, PA, 19067
Phone (267) 759-6300
Groups this clinician bills Medicare through
Medicare paid, 2024
$374K
9,078 services
Medicare patients, 2024
1,139
Average age 75
Drug cost, 2024
$2.0M
4,231 prescriptions
Company payments, 2025
$2,957
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter Serpico was code 99214 (office e&m - established), 1,180 times for 808 patients. In total Peter Serpico billed 9,078 services in 28 codes, and Medicare paid $374K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,180 | 808 | $95.97 | $113K |
| 94010 Pulmonary Function Testing | Office | 267 | 262 | $21.74 | $5,804 |
| 94726 Pulmonary Function Testing | Office | 249 | 245 | $44.71 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 240 | 165 | $61.64 | $15K |
| 94729 Pulmonary Function Testing | Office | 226 | 222 | $45.63 | $10K |
| 99204 Office E&M - New | Office | 158 | 158 | $122.18 | $19K |
| 94618 Pulmonary Function Testing | Office | 145 | 135 | $26.11 | $3,786 |
| 99222 Hospital E&M - Initial | Facility | 130 | 126 | $104.34 | $14K |
| 96372 Injection Administration | Office | 100 | 22 | $11.58 | $1,158 |
| 96160 E&M - Miscellaneous | Office | 93 | 83 | $2.28 | $212 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 42 | 40 | $11.06 | $465 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 32 | 31 | $27.06 | $866 |
| 94762 Pulmonary | Office | 27 | 26 | $20.84 | $563 |
| 99213 Office E&M - Established | Office | 23 | 22 | $66.22 | $1,523 |
By year: 2022 $340K for 7,281 services; 2023 $296K for 6,306 services; 2024 $374K for 9,078 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter Serpico prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 639 prescriptions and refills. In total Peter Serpico wrote 4,231 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 639 | 790 | 189 | $21K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 608 | 891 | 120 | $549K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 408 | 559 | 77 | $251K |
| Prednisone Generic | 255 | 293 | 98 | $1,033 |
| Montelukast Sodium Generic | 240 | 544 | 60 | $2,738 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 166 | 290 | 45 | $35K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 146 | 180 | 25 | $110K |
| Breo Ellipta Fluticasone/Vilanterol | 137 | 213 | 31 | $82K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 135 | 205 | 31 | $93K |
| Symbicort Budesonide/Formoterol Fumarate | 121 | 197 | 36 | $40K |
| Azithromycin Generic | 101 | 135 | 46 | $797 |
| Ropinirole Hcl Generic | 78 | 184 | 19 | $968 |
| Fluticasone Propionate Generic | 78 | 141 | 27 | $2,117 |
| Spiriva Respimat Tiotropium Bromide | 76 | 120 | 22 | $61K |
| Clonazepam Generic | 73 | 99 | 14 | $448 |
Brand drugs: 2,521 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter Serpico $2,957 ($2,957 in general payments such as food, travel and fees) from 27 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $701.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 32 | $701 |
| GlaxoSmithKline, LLC. GSK | 40 | $587 |
| Insmed, Inc. INSM | 19 | $207 |
| Verona Pharma, Inc. VRNA | 8 | $196 |
| Genzyme Corporation SNY | 6 | $182 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $112 |
| Genentech USA, Inc. ROG.SW | 4 | $105 |
| Grifols USA, LLC | 3 | $96.59 |
| Lilly USA, LLC LLY | 4 | $67.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.